Search research articles
Contact Us
Filters
Showing results (91-100 of 102) with videos related to
Page
of 11
Sort By:
Neuron
|
July 18, 2009
GOSPEL: a neuroprotective protein that binds to GAPDH upon S-nitrosylation
Nilkantha Sen, Makoto R Hara, Abdullah Shafique Ahmad, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 24, 2006
Mutant huntingtin: nuclear translocation and cytotoxicity mediated by GAPDH
Byoung-Il Bae, Makoto R Hara, Matthew B Cascio, et al.
Nature Cell Biology
|
June 17, 2008
Nitric oxide-induced nuclear GAPDH activates p300/CBP and mediates apoptosis
Nilkantha Sen, Makoto R Hara, Michael D Kornberg, et al.
International Journal of Immunogenetics
|
March 9, 2011
Exonic deletion of CASP10 in a patient presenting with systemic juvenile idiopathic arthritis, but not with autoimmune lymphoproliferative syndrome type IIa
H Tadaki, H Saitsu, H Kanegane, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 28, 2000
Treatment for pyothorax-associated lymphoma
T Aruga, J Itami, K Nakajima, et al.
Cell
|
October 22, 2003
Nitric oxide regulates exocytosis by S-nitrosylation of N-ethylmaleimide-sensitive factor
Kenji Matsushita, Craig N Morrell, Beatrice Cambien, et al.
Science Signaling
|
August 27, 2011
Distinct phosphorylation sites on the β(2)-adrenergic receptor establish a barcode that encodes differential functions of β-arrestin
Kelly N Nobles, Kunhong Xiao, Seungkirl Ahn, et al.
Nature Cell Biology
|
June 14, 2005
S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding
Makoto R Hara, Nishant Agrawal, Sangwon F Kim, et al.
Nature
|
August 23, 2011
A stress response pathway regulates DNA damage through β2-adrenoreceptors and β-arrestin-1
Makoto R Hara, Jeffrey J Kovacs, Erin J Whalen, et al.
Scandinavian Journal of Rheumatology
|
September 13, 2021
Favorable clinical response and drug retention of anti-IL-6 receptor inhibitor in rheumatoid arthritis with high CRP levels: the ANSWER cohort study
Y Nakayama, M Hashimoto, R Watanabe, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 102) with videos related to
Sort By:
Page
of 11
Neuron
|
July 18, 2009
GOSPEL: a neuroprotective protein that binds to GAPDH upon S-nitrosylation
Nilkantha Sen, Makoto R Hara, Abdullah Shafique Ahmad, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 24, 2006
Mutant huntingtin: nuclear translocation and cytotoxicity mediated by GAPDH
Byoung-Il Bae, Makoto R Hara, Matthew B Cascio, et al.
Nature Cell Biology
|
June 17, 2008
Nitric oxide-induced nuclear GAPDH activates p300/CBP and mediates apoptosis
Nilkantha Sen, Makoto R Hara, Michael D Kornberg, et al.
International Journal of Immunogenetics
|
March 9, 2011
Exonic deletion of CASP10 in a patient presenting with systemic juvenile idiopathic arthritis, but not with autoimmune lymphoproliferative syndrome type IIa
H Tadaki, H Saitsu, H Kanegane, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 28, 2000
Treatment for pyothorax-associated lymphoma
T Aruga, J Itami, K Nakajima, et al.
Cell
|
October 22, 2003
Nitric oxide regulates exocytosis by S-nitrosylation of N-ethylmaleimide-sensitive factor
Kenji Matsushita, Craig N Morrell, Beatrice Cambien, et al.
Science Signaling
|
August 27, 2011
Distinct phosphorylation sites on the β(2)-adrenergic receptor establish a barcode that encodes differential functions of β-arrestin
Kelly N Nobles, Kunhong Xiao, Seungkirl Ahn, et al.
Nature Cell Biology
|
June 14, 2005
S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding
Makoto R Hara, Nishant Agrawal, Sangwon F Kim, et al.
Nature
|
August 23, 2011
A stress response pathway regulates DNA damage through β2-adrenoreceptors and β-arrestin-1
Makoto R Hara, Jeffrey J Kovacs, Erin J Whalen, et al.
Scandinavian Journal of Rheumatology
|
September 13, 2021
Favorable clinical response and drug retention of anti-IL-6 receptor inhibitor in rheumatoid arthritis with high CRP levels: the ANSWER cohort study
Y Nakayama, M Hashimoto, R Watanabe, et al.
Page
of 11